ArticleCellular and molecular life sciences : CMLS2020

KHK inhibition for the treatment of hereditary fructose intolerance and nonalcoholic fatty liver disease: a double-edged sword.

Franciele Cabral Pinheiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.